Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000886163-11-000025)

Filing Details

Accession Number:: 0000886163-11-000025
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2011-03-03 13:59:15
Reporting Period:: 2011-02-24

Filing Date:: 2011-03-03
Accepted Time:: 2011-03-03 13:59:15
Original Submission Date:: 2011-02-28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
886163	Ligand Pharmaceuticals Inc	LGND	Pharmaceutical Preparations (2834)	770160744

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1223000	W John Kozarich	11085 North Torrey Pines Road, Suite 300 La Jolla CA 92037		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-02-24	1,000	$9.96	14,726	No	4	P	Direct
Common Stock	Acquisiton	2011-02-24	2,000	$10.00	16,726	No	4	P	Direct
Common Stock	Acquisiton	2011-02-24	211	$9.94	16,937	No	4	P	Direct
Common Stock	Acquisiton	2011-02-25	1,789	$9.99	18,726	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

This amendment is being made to correct the transaction code to reflect an open market purchase.